Philip L. Smith

Philip Smith became a director in 2016 and Chairman, Board of Directors in 2019. Philip has served as a managing director at the investment banking firm Duff & Phelps beginning in 2017, where he focuses on the healthcare industry. Prior to that, Philip was a managing director with the investment banking firm BMO Capital Markets (formerly Greene Holcomb Fisher). Prior to joining Greene Holcomb Fisher in 2011, he was president and CEO of Angeion Corporation, now MGC Diagnostics, a global medical technology company. Earlier experiences include being CEO of DGIMED Ortho, executive vice president of business development at Vital Images and a healthcare investment banker at Piper Jaffray.